Peter Whelan

3.6k citations

87 papers · 2.5k indexed · h-index 25

Impact in

Pulmonary and Respiratory Medicine top 1%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Urology top 1%
- Urological Disorders and Treatments

Papers in ⓘ

Pulmonary and Respiratory Medicine 48
- Prostate Cancer Treatment and Research 44
- Prostate Cancer Diagnosis and Treatment 33
Surgery 27
- Bladder and Urothelial Cancer Treatments 19
- Urinary and Genital Oncology Studies 12

Co-authors: J. P. BRITTON (6 shared papers)Anthony Dowell (5 shared papers)Laurence Collette (19 shared papers)Aldo Bono (4 shared papers)D.W.W. Newling (6 shared papers)L. Denis (4 shared papers)Jandeilson L. Moura (2 shared papers)R. Sylvester (2 shared papers)
Journals: European Urology (13 papers)The Journal of Urology (12 papers)Journal of Clinical Oncology (4 papers)The Prostate (3 papers)British Journal of Cancer (3 papers)
Partner nations: United Kingdom Netherlands Belgium

In The Last Decade

Peter Whelan

87 papers receiving 2.4k citations

Peers

Countries citing papers authored by Peter Whelan

Since Specialization

Citations

This map shows the geographic impact of Peter Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Whelan more than expected).

Fields of papers citing papers by Peter Whelan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Whelan. The network helps show where Peter Whelan may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Whelan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Whelan Line = papers co-authored together Peter Whelan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immediate or Deferred Androgen Deprivation for Patients With Prostate Cancer Not Suitable for Local Treatment With Curative Intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891 Journal of Clinical Oncology ·Urs E. Studer, Peter Whelan, Walter Albrecht, J Casselman, Theo de Reijke, D. Hauri, Wolfgang Loidl, Santiago Isorna, S.K. Sundaram, Muriel Debois, Laurence Collette	2006	225
2	Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853) Urology ·L. Denis, Jandeilson L. Moura, Aldo Bono, R. Sylvester, Peter Whelan, D.W.W. Newling, M. Depauw	1993	209
3	Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group European Urology ·Fernando E.C. Calais da Silva, Fernando E.C. Calais da Silva, Aldo Bono, Peter Whelan, Maurizio Brausi, Anton Marques Queimadelos, J A Portillo Martín, Ziya Kırkalı, Fernando M.V. Calais da Silva, Fernando M.V. Calais da Silva, Chris Robertson	2009	170
4	Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer Oncology ·Cora N. Sternberg, Peter Whelan, John Hetherington, B. Paluchowska, P. H. Th. J. Slee, K. Vekemans, P. Van Erps, Christine Théodore, O. Koriakine, R.T.D. Oliver, David Lebwohl, Muriel Debois, Alfredo Zurlo, Laurence Collette	2005	167
5	Maximal Androgen Blockade: Final Analysis of EORTC Phase III Trial 30853 European Urology ·L. Denis, F. Keuppens, P. H. SMITH, Peter Whelan, Jandeilson L. Moura, D.W.W. Newling, Aldo Bono, R. Sylvester	1998	138
6	A Community Study of Bladder Cancer Screening by the Detection of Occult Urinary Bleeding The Journal of Urology ·J. P. BRITTON, Anthony Dowell, Peter Whelan, Conrad M. Harris	1992	117
7	Similar Treatment Outcomes for Radical Cystectomy and Radical Radiotherapy in Invasive Bladder Cancer Treated at a United Kingdom Specialist Treatment Center International Journal of Radiation OncologyBiologyPhysics ·Sanjeev Kotwal, Ananya Choudhury, C.F. Johnston, Alan Paul, Peter Whelan, Anne E. Kiltie	2007	99
8	Dipstick haematuria and bladder cancer in men over 60: results of a community study. BMJ ·J. P. BRITTON, Anthony Dowell, Peter Whelan	1989	92
9	Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891) European Urology ·Urs E. Studer, Laurence Collette, Peter Whelan, Walter Albrecht, J Casselman, Theo de Reijke, H Knönagel, Wolfgang Loidl, Santiago Isorna, S.K. Sundaram, Muriel Debois	2007	79
10	Soluble forms of the adhesion molecule E-cadherin in urine. Journal of Clinical Pathology ·Rosamonde E. Banks, W H Porter, Peter Whelan, Philip H. Smith, Peter J. Selby	1995	68
11	The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853 European Journal of Cancer ·F.C. da Silva, Sophie D. Fosså, Neil K. Aaronson, S. Serbouti, L. Denis, J Casselman, Peter Whelan, John Hetherington, Carmen Fava, B. Richards, M. R. G. Robinson	1996	64
12	Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma PROTEOMICS ·Richard D. Unwin, Patricia Harnden, Darryl Pappin, Dinah Rahman, Peter Whelan, Rachel A. Craven, Peter J. Selby, Rosamonde E. Banks	2003	61
13	Prostate cancer treated by anti-androgens: is sexual function preserved? British Journal of Cancer ·Fritz H. Schröder, Laurence Collette, Theo M. de Reijke, Peter Whelan	2000	52
14	Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers Psychopharmacology ·Karen H Simpson, P. J. Murphy, P. V. Colthup, Peter Whelan	1992	50
15	Prevalence of Urinary Symptoms in Men Aged over 60 British Journal of Urology ·J. P. BRITTON, Anthony Dowell, Peter Whelan	1990	50
16	An Evaluation of the Immunochemical Measurement ofProstatic Acid Phosphatase and Prostatic Specific Antigen inCarcinoma of the Prostate European Urology ·J.K. Siddall, E.H. Cooper, D.W.W. Newling, M. R. G. Robinson, Peter Whelan	1986	49
17	Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up European Urology ·Urs E. Studer, Peter Whelan, Florian Wimpissinger, J Casselman, Theo M. de Reijke, H Knönagel, Wolfgang Loidl, Santiago Isorna, S.K. Sundaram, Laurence Collette	2013	45
18	An Evaluation of the Immunochemical Measurement of Prostatic Acid Phosphatase and Prostatic Specific Antigen in Carcinoma of the Prostate The Journal of Urology ·J.K. Siddall, E.H. Cooper, D.W.W. Newling, M. R. G. Robinson, Peter Whelan	1988	45
19	Zinc, Vitamin A and Prostatic Cancer British Journal of Urology ·Peter Whelan, B. E. Walker, J. Kelleher	1983	42
20	Metastatic Prostate Cancer Treated by Flutamide versus Cyproterone Acetate European Urology ·Fritz H. Schröder, Peter Whelan, Theo M. de Reijke, Karl H. Kurth, M. Pavone‐Macaluso, J Mattelaer, Roland F. van Velthoven, Muriel Debois, Laurence Collette	2003	41

About Peter Whelan

Peter Whelan is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Oncology and Urology, having authored 87 papers that have together received 2.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (33 papers), Bladder and Urothelial Cancer Treatments (19 papers), Urinary and Genital Oncology Studies (12 papers), Hormonal and reproductive studies (10 papers), Cancer, Lipids, and Metabolism (9 papers), Urological Disorders and Treatments (7 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Urology (276 citations), Endocrinology, Diabetes and Metabolism (468 citations), Cancer Research (279 citations) and Oncology (458 citations). Peter Whelan has collaborated with scholars based in United Kingdom, Netherlands and Belgium. Frequent co-authors include J. P. BRITTON, Anthony Dowell, Laurence Collette, Aldo Bono, D.W.W. Newling, L. Denis, Jandeilson L. Moura, R. Sylvester, Muriel Debois and J Casselman. Their work appears in journals such as European Urology, The Journal of Urology, Journal of Clinical Oncology, The Prostate and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact